UB-421(25 mg/kg) Q2W

BIOLOGICAL2 trials

Sponsors

United BioPharma, UBP Greater China (Shanghai) Co., Ltd

Conditions

HIV-1 InfectionHIV-1-infection

Phase 2

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

CompletedNCT03743376

United BioPharmaHIV-1 Infection

Start: 2018-12-12End: 2021-12-31Updated: 2022-05-13

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

UBP Greater China (Shanghai) Co., LtdHIV-1-infection

Start: 2023-12-01End: 2025-06-30Target: 39Updated: 2022-05-18